[Treatment of primary gastric lymphoma in IE/IIE stages]

The primitive gastric lymphoma constitutes 2-5% of malignant gastric neoplasms. The present treatment of such a pathology is not defined, since it seems that this disease deserves a multidisciplinary approach: surgical, chemotherapical, radiotherapical. The authors by means of this study, intend to estimate the results of the therapeutic treatment employed in 18 patients suffering from primitive gastric lymphoma in the stage IE and IIE. From the results obtained by our study, it emerges that in the lymphomata located in the cavity at the stage IE, there takes place the almost total superimposition of the results, in terms of survival to 5 years, in the patients treated surgically and in those treated by chemotherapy. Therefore, in such cases the chemotherapic treatment can be proposed because it is bloodless, the patient appreciates it more and it seems to be accompanied by a very small number of complications. In the patients with lymphomat located in the antrum at the stage IIE, we have obtained good results in terms of survival joining radiotherapy and chemotherapy to surgery, as reported by Moore. Even taking into account the very small number of cases we have considered, we think the primitive gastric lymphoma at the stage IE must be treated by means of chemotherapy, while that one at the stage IIE requires and integrated treatment.